The success rate of the procedure is usually around 90% and results are satisfactory in the term if increase in diameters of coarct segment, decrease in gradient across coarct segment and also reduction in systemic hypertension. There may be some complication related to stent implantation which includes aneurysm formation, restenosis, stent recoil and stent fracture. Re-dilatation or new stent implantation may be required in these situations. We perform Coarctation stenting routinely in patient weighting more than 15kg unless there is no other contraindication.
Case report:
M, a 4 years old male child was diagnosed as a case of patent ductus arteriosus and severe coarctation of aorta 3 months ago. He had history of exertional dyspnoea of grade II. A murmur was detected during examination and referred to pediatric cardiologist for work up.
His blood pressure were measured and upper limb pressure was 140/85 mmHg and lower limb pressure was 100/75 mmHg. So gradient was noticed and femoral pulse was feeble also. His chest x-ray showed cardiomegaly and ECG showed left ventricular hypertrophy. Echocardiography showed a large PDA of 3.5 mm size with severe coarctation of aorta. Gradient across coarctation segment was 55 mmHg.
On 15 th may 2015 he was taken into the catheterization laboratory of CMH Dhaka and device closure of PDA was performed with 10x8mm (Cera) device. Balloon angioplasty of coarctation was performed also with a 10mm x2cm 'Tyshak ' balloon. After procedure no gradient was noticed across the coarctation segment. Patient was discharged after 72 hours. In 24 hours follow up, echocardiography showed residual-coarctation with gradient of 20 mm Hg across coarct segment. Patient was advised to come after one month and echocardiography this time showed severe coarctation with gradient across coarct segment of 60 mmHg.
Stenting of Coarctation of Aorta in a Post Device Closure of Patent Ductus Arteriosus and Balloon Coarctoplasty patient: A Case Report
Echo also showed mild pericardial effusion and borderline LV function with dilated LV. CT angiogram of Aorta showed discrete severe coarctation. Patient weight was 11 kg. But we decided for stenting with Advanta V 12 covered stent. M was taken into cath lab on 27 th July 2015. A 0.35 wire was placed in ascending aorta through a multipurpose catheter. A Mullin sheath of 9f size was placed crossing coarct segment. Balloon mounted stent was forwarded over the wire to coarct segment and inflated up to 11 ATM to dilate it up to 12.5mm. Post inflation pressure above and below the isthmus was measured. It was zero after procedure. Patient's hemodynamics were stable throughout procedure. Heart rate was increased to 200beats/min during balloon dilatation with Injection Atropine. Patient was shifted to Paediatric cardiac ICU after hemostasis and heparin infusion was continued for 48 hours. Tab. Aspirin 5mg/kg started and advised to continue for 6 months. Injection-Ceftriaxone 50mg/kg IV was given during the procedure and then once daily for 72 hours. Patient was discharged 72 hours after procedure. He was advised to come for follow up after 1 month. Stenting of Coarctation of Aorta in a Post Device Closure of Patent Nurun NaharFatema
Procedure:

Discussion:
Coarctation of Aorta (CoA) occurred in 5% of all congenital heart disease. 1 Coarctation of aorta is typically discrete stenosis in the upper thoracic aorta, at or near the insertion of the ductus arteriosus. The anatomy of coarctation includes intimal and medial malformation and a posterior infolding of these two layers. Coarctation of aorta associated with isthmus or arch hypoplasia or it may be long segment or tortuous. 2 Balloon dilatation has gained acceptance in the treatment of native and recurrent coarctation but significant number of cases develop re coarctation after balloon angioplasty. 3, 4 This is related to elastic recoil of the vessel. Stent provide radial strength to avoid recoil of the vessel and frame work for endothelial growth. 5 Stents are gaining popularity in treating coarctation over last few years. But there are some limitations of stents also which includes flexibility, large delivery system to introduce into child or young adult, ability to further re-dilatation to adult size, radial strength, sharp edges, ability to reposition, allowing access to side branch for covered stentetc. [6] [7] [8] The advancement of stent technology aimed to address these desirable characteristics. The most commonly used stent is the balloon expandable stent which allows further expansion of the stent as patient grows. Commonly used stents and Cheathum (CP) covered stents, Advanta V 12 Atrium stents, Palmaz stents, Intrastents etc. [9] [10] [11] [12] In our patient we used Atrium v 12 Advanta 12x36 mm balloon expandable stent.
It is well established that Doppler Echocardiography is the gold standard to diagnose severity and location of coarctation of the aorta. MRI is a good alternative and reliable non-invasive method to depict aortic arch anatomy. Cine MRI and post contrast record allow finding high velocity Jet, peaking systolic velocity and qualification.
CT scan is also used to calculate aortic diameter and is recommended in patient with pacemaker, defibrillator, prosthesis, clips etc. We did CT angiography as MRI machine was out of order in our hospital. This procedure is usually done under general anesthesia but we performed under deep sedation.
The choice of stent diameter and length is a major concern for stent implantation. The stent must cover the coarctation segment without protrusion into left subclavian artery. Stent diameter based mainly on transverse or distal arch diameter or diameter of proximal Aorta. Usually stent selected are 1-2 mm more in size. In our case transverse arch was 11 mm and we selected 12 mm stent. Descending aorta diameter at the level of diaphragm was 12 mm. Ratio of expansion of coarctation segment is around 2 to 3.5 and should be <3.5.
The stent implantation is considered successful if residual gradient is <10 mm Hg. In our case it was 0 mmHg immediately after the procedure. The most serious complication of stenting is rupture of aorta which may lead to death; others are stent migration, stent fracture, aneurysm formation, embolization of stent etc. Restenosis is another issue which has been reported in 13-31% cases.
Comparison between surgery and stenting showed lower morbidity (9%) in stent group to 11% in surgery group. 13
Conclusion:
Patient with coarctation of aorta have a high risk of late cardiovascular morbidity and mortality mainly related to systemic hypertension. Other potential complications include coronary artery disease, sudden cardiac death, heart failure and stroke. So these patients should be treated immediately after diagnosis. Coarctoplasty with stenting is a safe and effective modality of treatment for these group of patients.
